Publication of clinical trials in JAMA: Information for authors

JAMA

Volumn 299, Issue 1, 2008, Pages 95-96

  Fontanarosa, Phil B ^a   DeAngelis, Catherine D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTHOR; CLINICAL RESEARCH; EDITOR; EDITORIAL; MEDICAL LITERATURE; PRIORITY JOURNAL; PUBLICATION; PUBLISHING;

EID: 38049047590     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2007.28     Document Type: Editorial

References (14)

1. JAMA's Key and Critical Objectives. http://jama.ama-assn.org/misc/ aboutjama.dtl. Accessed December 11, 2007.
2. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA. 2002;288(3):321-333.
3. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004;291(14):1701-1712.
4. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981-2997.
5. Vogel VG, Constantino JP, Wickerham DL, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA. 2006;295(23):2727-2741.
6. Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA. 2003;290(17):2292-2300.
7. Shaddy RE, Boucek MM, Hsu DT, et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA. 2007;298(10):1171-1179.
8. Instructions for authors. JAMA. 2008;299(1):jin022008. http://jama.ama-assn.org/misc/ifora.dtl. Accessed December 12, 2007.
9. DeAngelis CD, Drazen JM, Frizelle FA, et al. Is this clinical trial fully registered? a statement from the International Committee of Medical Journal Editors. JAMA. 2005;293(23):2927-2929.
10. Laine C, Horton R, DeAngelis CD, et al. Clinical trial registration: looking back and moving ahead. JAMA. 2007;298(1):93-94.
11. Food and Drug Amendments Act of 2007. Pub L 110-85. September 27, 2007.
12. The CONSORT statement. http://www.consort-statement.org/index.aspx?o= 1011. Accessed December 10, 2007.
13. Fontanarosa PB, Flanagin A, DeAngelis CD. Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies. JAMA. 2005;294(1):110-111.
14. Winker MA, Fontanarosa PB. JAMA-EXPRESS: rapid peer review and publication. JAMA. 1999;281:1754-1755.